Navigation Links
Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Date:8/19/2007

months ended June 30, 2007 was $9.7 million as compared to $28.1 million for the same period in 2006. On a Non-GAAP basis, the net loss for the three months ended June 30, 2007 and the three months ended June 30, 2006 was $8.3 million, respectively. The Company recorded no revenues during these periods.

On a Non-GAAP basis, research and development expense for the three months ended June 30, 2007, was $6.4 million, an increase of $0.1 million from $6.3 million for the three months ended June 30, 2006.

On a Non-GAAP basis, general and administrative expense for the three months ended June 30, 2007, was $2.6 million, an increase of $0.4 million from $2.2 million from the three months ended June 30, 2006.

The differences between U.S. GAAP EPS, net loss, research and development and general and administrative and the corresponding non-GAAP amounts are itemized in table 2, and are due to:

-- Pre-tax share-based compensation expense under SFAS 123R of

$1.0 million (or $0.14 per share), primarily related to employee stock

option expense.

-- Pre-tax charge for a deemed dividend of $19.4 million in the second

quarter of 2006.

-- Pre-tax charges for preferred stock accretion.

-- Pre-tax charges for changes in the fair value of warrant liability.

Use of Non-GAAP Financial Measures

Our "non-GAAP net income" and "non-GAAP diluted EPS" financial measures are defined as reported, or GAAP, net income and diluted EPS excluding, for the reasons discussed below, (1) stock option expense and the cumulative effect of an accounting change relating to the initial adoption of SFAS No. 123R and (2) other items. Our management uses these non-GAAP financial measures to establish financial goals and to gain an understanding of the comparative financial performance of the Company from year to year and quarter to quarter. Accordingly, we believe investors' understanding of the Company's financial performance is enha
'/>"/>

SOURCE Amicus Therapeutics

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera for Gaucher Disease
2. Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
3. Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
8. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
9. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
10. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
11. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  A prospective study ... Sweden has validated the performance of ... and has associated volumetrically assessed breast density measurements ... Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the ... tool for widespread breast cancer risk assessment," was ...
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
(Date:7/28/2014)...  ResMed (NYSE: RMD ), an innovator ... sleep-disordered breathing and other chronic respiratory conditions, has won ... against Taiwanese medical device manufacturer APEX Medical Corp. (APEX), ... 210 and 220 masks.  The judgment was entered by ... , is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... Calif., Oct. 31, 2011 Claret Medical, Inc. announced ... approval as the world,s first complete system of filtration ... is delivered via radial or brachial access, providing complete ... Valve Intervention (TAVI).  The unique design of the Montage ...
... Oct. 31, 2011 At the American ... Renal Research Institute, LLC (RRI) is presenting research results from ... dedicated to advancing therapy options for dialysis patients to provide ... ASN,s Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, ...
Cached Medicine Technology:Claret Medical Announces CE Mark of a New Embolic Protection System to Address Stroke During Transcatheter Aortic Valve Intervention 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 3
(Date:7/28/2014)... new study of the European project SOPHIE has ... policies and gender inequalities in health in Europe. ... policies (central and southern Europe) and countries with ... self-perceived health, i.e. women reported poorer health than ... Europe countries, where women present a 27% higher ...
(Date:7/28/2014)... CA (PRWEB) July 28, 2014 Top ... $100 coupon for new patients. Finding a new dentist can ... or dental issues that have gone untreated and worry about ... Dr. Ariz specializes in patients with special concerns and dental ... feels comfortable and right at home. This special coupon can ...
(Date:7/28/2014)... July 28, 2014 What if you ... lifestyle can often be a struggle that requires personal ... and medium, Lynette Leckie-Clark provides simple how-to steps on ... Magic of You.” With inspiring spiritual affirmations and life ... find empowerment, confidence and motivation for everyday life. ...
(Date:7/28/2014)... "I injured my shoulder and had to have ... Sunnyvale, Calif. "When I slept in one, I almost strangled ... and require too many straps. That is why I came ... Vest to improve the design of a standard sling. The ... properly. This helps to speed up the healing process. The ...
(Date:7/28/2014)... Humility of Mary Health Partners will offer a one-hour ... Health Center, 8401 Market St., Boardman. , The workshop includes ... 200 common health problems as well as tips on caring ... advice on when to seek medical attention. , The ... session runs from 5:30 to 6:30 p.m. The workshop and ...
Breaking Medicine News(10 mins):Health News:Gender inequalities in health: A matter of policies 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Be Empowered to Achieve Happiness from New Book "The Magic of You" 2Health News:HMHP Offers ‘Health at Home’ Workshop 2
... is studying the differences between the social impairments found ... for people with both disorders. Autism spectrum disorder ... but they share similarities in social dysfunction. For many ... young people with ASD were thought to have a ...
... heart disease may not be able to compensate for their ... to Penn State researchers, making snow shoveling and other activities ... why cold air is such a trigger for coronary events," ... of the Heart and Vascular Institute, Penn State College of ...
... LANSING, Mich. Often faced with overwhelming anxiety, patients newly ... new research recommends nurses play a key role in alleviating ... A diagnosis of lung cancer the leading cause ... it high levels of stress and raises existential issues and ...
... , TUESDAY, Feb. 28 (HealthDay News) -- ... the chances that those addicted to opioids who have ... habit, a new study shows. Opioid abuse includes ... and the nonmedical use of prescription painkillers such as ...
... BLOOMINGTON, Ind. -- U.S. industry and environmental groups agree ... needs to be modernized to better protect public health ... what the reform should look like. A new ... the European Union,s reformed chemicals law REACH (Registration, Evaluation, ...
... deal has been learned in the ten years since the ... therapy (HT) remains the most effective treatment available for menopausal ... body of evidence that formulation, route of administration, timing of ... It is essential to evaluate a personal benefit-risk profile ...
Cached Medicine News:Health News:Study compares traits of autism, schizophrenia 2Health News:Cold air chills heart's oxygen supply 2Health News:Nurses key in helping new cancer patients overcome fears 2Health News:Drug-Free Housing Helps Heroin, Oxycontin Addicts Recover 2Health News:Report examines what US can learn from EU chemicals law 2Health News:The North American Menopause Society (NAMS) reassures many women 2
Lumicon 48 mm red filter....
Doctors six-pack long lasting, disposable, diagnostic penlights. Constant use time of 30 minutes. One year shelf life warranty from date of purchase. Convenient clip-activated switch & imprinted medi...
Features a twist-on backswitch with a diffused, cobalt blue, light beam. Packaged with fluorescein strips....
... integrates the latest in auto focus. The ... computer monitors or televisions to create a ... individuals unique viewing needs. Using advanced technology ... the Genie Pro allows a user to ...
Medicine Products: